Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-01-29

Clinical Trial Update: Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™ [NA]

View source ↗

Summary

The early feasibility study of the AcoustiCare device for heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AcoustiCare

Snippet

Sponsor: Signature Medical, Inc. | Conditions: Heart Failure,Congestive | NA | Status: WITHDRAWN